Allspring Global Investments
APYX icon

Allspring Global Investments’s Apyx Medical APYX Stock Holding History

Allspring Global Investments’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,277
Closed -$256K – 2691
2022
Q1 		$256K Sell
39,277
-34,451
-47% -$339K ﹤0.01% 2490
2021
Q4 		$945K Buy
+73,728
New +$1.03M ﹤0.01% 1976

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Allspring Global Investments's APYX Position: Q2 2022 in Review

Allspring Global Investments sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 39,277 shares — an estimated $256K sold.

Allspring Global Investments first reported a position in APYX in Q4 2021 and held it in 2 quarters. The position peaked at $945K in Q4 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Allspring Global Investments reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 39,277 Apyx Medical shares in Q2 2022, an estimated $256K.
  • Allspring Global Investments first reported a position in Apyx Medical in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Apyx Medical position peaked at $945K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.